Literature DB >> 32038810

Subcutaneous Four-Week Repeated Dose Toxicity Studies of Rice Cell-Derived Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Rats.

Jung Eun Ji1, Jung Min Lee1, Jong Min Choi1, Young Hwa Choi1, Eun Kyung Kim1, So Jung Chu1, Seok Kyun Kim1, Kyong Hoon Ahn1, Dong Hoon Lee1, Ha Hyung Kim1, Kyuboem Han2, Dae Kyong Kim1.   

Abstract

Recombinant human granulocyte-macrophage colony stimulating factor (hGM-CSF) is a glycoprotein and hematopoietic growth factors that regulates the proliferation of myeloid precursor cells and activates mature granulocytes and macrophages. In a previous study, we reported that hGM-CSF could be produced in transgenic rice cell suspension culture, termed rhGM-CSF. In the present study, we examined the repeated dose toxicity of rhGM-CSF in SD rats. The repeated dose toxicity study was performed at each dose of 50 and 200 µg/kg subcutaneous administration of rhGM-CSF everyday for 28-days period. The results did not show any changes in food and water intake. There were also no significant changes in both body and organ weights between the control and the tested groups. The hematological and blood biochemical parameters were statistically not different in all groups. These results suggest that rhGM-CSF may show no repeated dose toxicity in SD rats under the conditions. © Korean Society of Toxicology 2008.

Entities:  

Keywords:  Recombinant hGM-CSF; Repeated dose toxicity; Rice cells; SD rats

Year:  2008        PMID: 32038810      PMCID: PMC7006265          DOI: 10.5487/TR.2008.24.4.315

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


  20 in total

Review 1.  Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

Authors:  G J Lieschke; A W Burgess
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

2.  Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on 5-FU-induced ulcerative mucositis in hamster buccal pouches.

Authors:  Sun-A Cho; Jong-Hwan Park; Seung-Hyeok Seok; Jae-Hyeon Juhn; Seong-Jin Kim; Hyi-Jeong Ji; Youn-Sung Choo; Jae-Hak Park
Journal:  Exp Toxicol Pathol       Date:  2006-01-18

3.  The glycosylation and in vivo stability of human granulocyte-macrophage colony-stimulating factor produced in rice cells.

Authors:  Hyoung Jin Kim; Dong Hoon Lee; Dae Kyong Kim; Gyu-Bum Han; Hong-Jin Kim
Journal:  Biol Pharm Bull       Date:  2008-02       Impact factor: 2.233

Review 4.  Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  J O Armitage
Journal:  Blood       Date:  1998-12-15       Impact factor: 22.113

5.  High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture.

Authors:  Yun-Ji Shin; Shin-Young Hong; Tae-Ho Kwon; Yong-Suk Jang; Moon-Sik Yang
Journal:  Biotechnol Bioeng       Date:  2003-06-30       Impact factor: 4.530

6.  Induction of anti-recombinant human granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients.

Authors:  P Ragnhammar; H J Friesen; J E Frödin; A K Lefvert; M Hassan; A Osterborg; H Mellstedt
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

Review 7.  Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony-stimulating factor.

Authors:  R T Dorr
Journal:  Clin Ther       Date:  1993 Jan-Feb       Impact factor: 3.393

8.  Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells.

Authors:  F Lee; T Yokota; T Otsuka; L Gemmell; N Larson; J Luh; K Arai; D Rennick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins.

Authors:  G G Wong; J S Witek; P A Temple; K M Wilkens; A C Leary; D P Luxenberg; S S Jones; E L Brown; R M Kay; E C Orr
Journal:  Science       Date:  1985-05-17       Impact factor: 47.728

10.  Potential utility of recombinant human GM-CSF as adjunctive treatment of refractory oropharyngeal candidiasis in AIDS patients.

Authors:  J A Vazquez; S Gupta; A Villanueva
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.